At 12:28 IST, the barometer index, the S&P BSE Sensex, was down 290.22 points or 0.46% to 62,544.38. The Nifty 50 index lost 84.70 points or 0.45% to 18,616.35.
In the broader market, the S&P BSE Mid-Cap index slipped 0.43% while the S&P BSE Small-Cap index declined 0.22%.
The market breadth was negative. On the BSE, 1,588 shares rose, and 1,766 shares fell. A total of 165 shares were unchanged.
The Reserve Bank of India (RBI) started its bi-monthly policy review with the Monetary Policy Committee (MPC) meeting yesterday. The bi-monthly policy review is expected to come out on 7 December 2022. More than the quantum of rate hikes, domestic investors would watch out for RBI's commentary as it ramps up its efforts to curb inflation and push growth.
On the political front, various exit polls on Monday predicted a big majority for the BJP in Gujarat and a dead heat in Himachal Pradesh where most pollsters gave an edge to the ruling party over the Congress. The counting of votes in both states will take place on December 8. Elections for the Himachal Pradesh assembly took place on November 12, while polling in Gujarat happened in two phases on December 1 and 5.
Derivatives:
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rose 2.25% to 14.04. The Nifty 29 December 2022 futures were trading at 18,732, at a premium of 115.65 points as compared with the spot at 18,616.35.
The Nifty option chain for the 29 December 2022 expiry showed maximum Call OI of 35 lakh contracts at the 19,000 strike price. Maximum Put OI of 31.8 lakh contracts were seen at 18,000 strike price.
Buzzing Index:
The Nifty Pharma index fell 0.97% to 12,926.55. The index declined 1.66% in past four trading sessions.
Glenmark Pharmaceuticals (down 2.48%), Biocon (down 1.81%), Dr Reddys Laboratories (down 1.54%), Granules India (down 1.48%), Sun Pharmaceuticals Industries (down 1.37%), Ipca Laboratories (down 1.16%), Glaxosmithkline Pharmaceuticals (down 1.07%), Cipla (down 1%), Zydus Lifesciences (down 0.88%) and Torrent Pharmaceuticals (down 0.86%) declined.
On the other hand, Natco Pharma (up 0.87%), Sanofi India (up 0.32%) and Abbott India (up 0.31%) advanced.
Stocks in Spotlight:
Ratnamani Metals & Tubes rose 0.16% after the iron & steel producer said that it has recently received new orders aggregating to Rs 262.52 crore. The company has bagged domestic orders aggregating to Rs 233.26 crore. It has also secured export orders aggregating to Rs 29.26 crore.
Gravita India jumped 2.08% after the company said its step down subsidiary, Gravita Togo SAU, has started aluminium recycling plant in West Africa. Gravita Togo SAU has started commercial production of aluminium cast-alloys from a new recycling plant having an annual capacity of around 4,000 MTPA in phase I.
Force Motors advanced 0.68% after the company registered 110.2% jump in domestic sales to 1,623 units in November 2022 from 772 units sold in November 2021. As compared with October 2022, the domestic sales declined 22.3% last month.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
